NB
DXCM icon

Norinchukin Bank’s DexCom DXCM Stock Holding History

Norinchukin Bank’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.57M Buy
38,224
+171
+0.4% +$11.4K 0.03% 294
2026
Q1 		$2.39M Buy
38,053
+856
+2% +$59.6K 0.03% 286
2025
Q4 		$2.47M Buy
37,197
+3,522
+10% +$228K 0.03% 276
2025
Q3 		$2.27M Buy
33,675
+74
+0.2% +$5.86K 0.03% 279
2025
Q2 		$2.93M Buy
33,601
+1,953
+6% +$153K 0.04% 232
2025
Q1 		$2.16M Buy
31,648
+9,608
+44% +$784K 0.04% 257
2024
Q4 		$1.71M Buy
22,040
+1,664
+8% +$123K 0.04% 261
2024
Q3 		$1.37M Buy
20,376
+3,033
+17% +$249K 0.03% 296
2024
Q2 		$1.97M Buy
17,343
+860
+5% +$109K 0.06% 186
2024
Q1 		$2.29M Sell
16,483
-372
-2% -$46.8K 0.07% 174
2023
Q4 		$2.09M Sell
16,855
-2,253
-12% -$230K 0.05% 175
2023
Q3 		$1.78M Sell
19,108
-17,198
-47% -$1.94M 0.04% 205
2023
Q2 		$4.67M Buy
36,306
+7,048
+24% +$852K 0.08% 164
2023
Q1 		$3.4M Buy
29,258
+759
+3% +$85K 0.07% 167
2022
Q4 		$3.23M Sell
28,499
-6,019
-17% -$661K 0.07% 165
2022
Q3 		$2.78M Buy
34,518
+3,022
+10% +$256K 0.06% 202
2022
Q2 		$2.35M Sell
31,496
-8,316
-21% -$759K 0.05% 224
2022
Q1 		$5.09M Buy
39,812
+3,400
+9% +$372K 0.07% 165
2021
Q4 		$4.89M Sell
36,412
-2,188
-6% -$314K 0.06% 165
2021
Q3 		$5.28M Buy
38,600
+2,168
+6% +$273K 0.07% 144
2021
Q2 		$3.89M Buy
36,432
+700
+2% +$67.2K 0.06% 171
2021
Q1 		$3.21M Buy
35,732
+1,688
+5% +$158K 0.04% 192
2020
Q4 		$3.15M Sell
34,044
-36
-0.1% -$3.21K 0.04% 173
2020
Q3 		$3.51M Buy
34,080
+2,192
+7% +$229K 0.06% 147
2020
Q2 		$3.23M Buy
+31,888
New +$2.85M 0.06% 153

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norinchukin Bank's DXCM Position: Q2 2026 in Review

Norinchukin Bank increased its DexCom (DXCM) stake by 0.45% in Q2 2026, buying an estimated $11.4K and bringing the position to 38,224 shares worth $2.57M. The position accounts for 0.03% of the portfolio, ranked #294.

Norinchukin Bank first reported a position in DXCM in Q2 2020 and has held it in 25 quarters since. The position peaked at $5.28M in Q3 2021. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Norinchukin Bank held 38,224 shares of DexCom worth $2.57M as of Q2 2026.
  • Norinchukin Bank bought 171 DexCom shares in Q2 2026, an estimated $11.4K.
  • DexCom made up 0.03% of Norinchukin Bank's portfolio in Q2 2026, its #294 holding.
  • Norinchukin Bank first reported a position in DexCom in Q2 2020 and has held it in 25 quarters since.
  • Norinchukin Bank's DexCom position peaked at $5.28M in Q3 2021.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Norinchukin Bank's 13F filing for Q2 2026, filed 14 Aug 2026.